These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1472112)

  • 1. Does sorbinil bind to the substrate binding site of aldose reductase?
    Liu SQ; Bhatnagar A; Srivastava SK
    Biochem Pharmacol; 1992 Dec; 44(12):2427-9. PubMed ID: 1472112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition.
    Bohren KM; Grimshaw CE
    Biochemistry; 2000 Aug; 39(32):9967-74. PubMed ID: 10933817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
    El-Kabbani O; Old SE; Ginell SL; Carper DA
    Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the reduction of 3-acetylpyridine adenine dinucleotide phosphate by benzyl alcohol catalyzed by aldose reductase.
    Griffin BW; McNatt LG
    Arch Biochem Biophys; 1986 Apr; 246(1):75-81. PubMed ID: 3083781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.
    O'Brien MM; Schofield PJ; Edwards MR
    J Neurochem; 1982 Sep; 39(3):810-4. PubMed ID: 6808090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
    Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of an aldose reductase inhibitor to renal glomeruli.
    Cohen MP; Klepser H
    Biochem Biophys Res Commun; 1985 Jun; 129(2):530-5. PubMed ID: 3925947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the inhibitor-binding site of aldose reductase with site-directed mutagenesis.
    Hohman TC; El-Kabbani O; Malamas MS; Lai K; Putilina T; McGowan MH; Wane YQ; Carper DA
    Eur J Biochem; 1998 Sep; 256(2):310-6. PubMed ID: 9760169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding.
    Bhatnagar A; Liu SQ; Ueno N; Chakrabarti B; Srivastava SK
    Biochim Biophys Acta; 1994 Apr; 1205(2):207-14. PubMed ID: 8155699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of an orally absorbed aldose reductase inhibitor, sorbinil.
    Foulds G; O'Brien MM; Bianchine JR; Gabbay KH
    Clin Pharmacol Ther; 1981 Nov; 30(5):693-700. PubMed ID: 6794971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.
    Urzhumtsev A; Tête-Favier F; Mitschler A; Barbanton J; Barth P; Urzhumtseva L; Biellmann JF; Podjarny A; Moras D
    Structure; 1997 May; 5(5):601-12. PubMed ID: 9195881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine lens aldose reductase. pH-dependence of steady-state kinetic parameters and nucleotide binding.
    Liu SQ; Bhatnagar A; Srivastava SK
    J Biol Chem; 1993 Dec; 268(34):25494-9. PubMed ID: 8244985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE; Lai CJ
    Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.
    Sellers DJ; Chess-Williams R
    J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on L-threose as substrate for aldose reductase: a possible role in preventing protein glycation.
    Devamanoharan PS; Varma SD
    Mol Cell Biochem; 1996 Jun; 159(2):123-7. PubMed ID: 8858562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition.
    Grimshaw CE; Bohren KM; Lai CJ; Gabbay KH
    Biochemistry; 1995 Nov; 34(44):14374-84. PubMed ID: 7578041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.